Strong overall survival (OS) results with a 12-month OS rate of 67% in difficult-to-treat head and neck cancer patients, indicating potential for improved patient outcomes. Increased complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback